Isradipine: A potent antagonist of CALCIUM CHANNELS that is highly selective for VASCULAR SMOOTH MUSCLE. It is effective in the treatment of chronic stable angina pectoris, hypertension, and congestive cardiac failure.
Article | Year |
[Severe obstructive lung disease. The effect of the calcium antagonist isradipine on working capacity, pulmonary function, morbidity and survival].Ugeskrift for laeger, 1993, Aug-23, Volume: 155, Issue:34
Topics: Adult; Aged; Denmark; Double-Blind Method; Female; Hemodynamics; Humans; Isradipine; Lung Diseases, | 1993 |
Atrial natriuretic peptide (ANP) in chronic obstructive pulmonary disease (COPD): the relationship between plasma ANP and lung function. Effects of exercise and of the calcium antagonist, isradipine, on plasma ANP. A randomised, double-blind, placebo-contHormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1992, Volume: 24, Issue:3
Topics: Atrial Natriuretic Factor; Calcium Channel Blockers; Dihydropyridines; Humans; Isradipine; Lung; Lun | 1992 |
The effect of the calcium antagonist, isradipine, on working capacity, pulmonary function, morbidity and survival rate in patients with severe chronic obstructive pulmonary disease (COPD): a randomized, double-blind, placebo-controlled study.Journal of internal medicine, 1991, Volume: 229, Issue:5
Topics: Aged; Blood Pressure; Calcium Channel Blockers; Double-Blind Method; Exercise Test; Humans; Isradipi | 1991 |
Erythropoietin in chronic obstructive pulmonary disease. Relationship between serum erythropoietin, blood hemoglobin and lung function--effect of the calcium antagonist isradipine on serum erythropoietin.Respiration; international review of thoracic diseases, 1991, Volume: 58, Issue:3-4
Topics: Aged; Calcium Channel Blockers; Dihydropyridines; Double-Blind Method; Erythropoietin; Forced Expira | 1991 |